Decreased hippocampal metabolism in high-amyloid mild cognitive impairment

Area of Science:

• Neuroscience
• Medical Imaging
• Alzheimer's Disease Research

Background:

• Mild cognitive impairment (MCI) is associated with decreased hippocampal volume (HV), cortical metabolism, and thickness.
• Previous studies on hippocampal metabolism (HM) in MCI versus clinically normal (CN) elderly have yielded inconsistent results.
• The hippocampus is a critical region affected in Alzheimer's disease (AD).

Purpose of the Study:

• To investigate the hypothesis that HM is specifically decreased in MCI patients with high amyloid burden.
• To examine the interaction between clinical status (MCI vs. CN) and amyloid status on HM, HV, cortical metabolism, and thickness.

Main Methods:

• Utilized three-dimensional magnetic resonance imaging (MRI), fludeoxyglucose-positron emission tomography (FDG-PET), and Pittsburgh Compound B (PiB) PET.
• Included 250 CN and 45 MCI participants.
• Employed linear models, covarying for age, gender, and education, with and without corrections for multiple comparisons and partial volume effects.

Main Results:

• Volume-adjusted HM was reduced in high-amyloid MCI but not in low-amyloid MCI or high-amyloid CN.
• Both MCI groups exhibited hippocampal atrophy, with less severity in the low-amyloid MCI group.
• High-amyloid CN and high-amyloid MCI groups showed cortical hypometabolism.

Conclusions:

• Hippocampal metabolism is significantly decreased when both cognitive impairment and amyloid pathology are present.
• Amyloid burden plays a crucial role in the observed reduction of HM in MCI.
• These findings contribute to understanding the neurobiological underpinnings of cognitive decline in AD.